login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
OPTIMIZERX CORP (OPRX) Stock News
USA
- NASDAQ:OPRX -
US68401U2042
-
Common Stock
15.65
USD
-3.29 (-17.37%)
Last: 11/7/2025, 8:06:12 PM
15.89
USD
+0.24 (+1.53%)
After Hours:
11/7/2025, 8:06:12 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
OPRX Latest News, Press Relases and Analysis
All
Press Releases
3 days ago - By: Chartmill
OptimizeRx Corp (NASDAQ:OPRX) Shows High-Growth Momentum with Strong Technical Breakout
3 days ago - By: Chartmill
OptimizeRx Corp (NASDAQ:OPRX) Delivers Strong Q3 Beat and Raises Guidance
2 hours ago - By: The Motley Fool
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript
3 days ago - By: Zacks Investment Research
- Mentions:
MGIC
OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates
3 days ago - By: Benzinga
- Mentions:
CERS
WORX
IRD
CMND
...
12 Health Care Stocks Moving In Thursday's After-Market Session
3 days ago - By: OptimizeRx Corporation
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
3 days ago - By: OptimizeRx Corporation
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
4 days ago - By: Benzinga
- Mentions:
STVN
PODD
AMRK
SOLV
...
Earnings Scheduled For November 6, 2025
21 days ago - By: OptimizeRx Corporation
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
21 days ago - By: OptimizeRx Corporation
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
a month ago - By: Zacks Investment Research
OptimizeRx Corp. (OPRX) is a Great Momentum Stock: Should You Buy?
a month ago - By: Zacks Investment Research
- Mentions:
OMCL
TDOC
OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off?
2 months ago - By: OptimizeRx Corporation
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
2 months ago - By: OptimizeRx Corporation
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
2 months ago - By: OptimizeRx Corporation
- Mentions:
LAMR
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
2 months ago - By: OptimizeRx Corporation
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
2 months ago - By: Zacks Investment Research
- Mentions:
KT
GLDD
Best Growth Stocks to Buy for September 5th
2 months ago - By: Zacks Investment Research
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now?
3 months ago - By: Zacks Investment Research
All You Need to Know About OptimizeRx (OPRX) Rating Upgrade to Strong Buy
3 months ago - By: Zacks Investment Research
- Mentions:
BZ
ANET
Best Momentum Stock to Buy for August 21st
3 months ago - By: OptimizeRx Corporation
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
3 months ago - By: OptimizeRx Corporation
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
3 months ago - By: Zacks Investment Research
- Mentions:
SPNS
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates
3 months ago - By: OptimizeRx Corporation
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
3 months ago - By: OptimizeRx Corporation
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
3 months ago - By: Zacks Investment Research
- Mentions:
SHOP
VIPS
STNE
Shopify Q2 Earnings Beat Estimates, Revenues Jump Y/Y, Shares Rise
3 months ago - By: Zacks Investment Research
- Mentions:
FSLY
VIPS
STNE
Fastly Posts Narrower Loss in Q2 Earnings, Revenues Rise Y/Y
Please enable JavaScript to continue using this application.